0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Angiogenesis Assay Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
Published Date: August 2025
|
Report Code: QYRE-Auto-11S9277
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Angiogenesis Assay Market Size Status and Forecast 2022
BUY CHAPTERS

Global Angiogenesis Assay Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Code: QYRE-Auto-11S9277
Report
August 2025
Pages:80
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Angiogenesis Assay Sales Market Size

The global Angiogenesis Assay market size was US$ 20.9 million in 2024 and is forecast to a readjusted size of US$ 35.1 million by 2031 with a CAGR of 7.8% during the forecast period 2025-2031.

Angiogenesis Assay Sales Market

Angiogenesis Assay Sales Market

Angiogenesis is the tightly regulated process by which new blood vessels are formed from the existing vasculature. This process is physiologically important for development and wound healing, and is also a common driver in multiple diseases including rheumatoid arthritis, atherosclerosis, macular degeneration, and cancer. Angiogenesis occurs in response to a variety of molecular cues. Generally, the angiogenic process includes endothelial cell proliferation, chemotactic endothelial cell migration through the extracellular matrix barrier, and the formation of capillary tubes. Physiological and pathological angiogenesis utilize many of the same cellular processes and molecular signaling networks, however the structures that form during pathological angiogenesis are often functionally abnormal.
Global Angiogenesis Assay key players include Abcam, Bio-Techne, Thermo Fisher Scientific, PromoCell GmbH, Merck KGaA, etc. Global top five manufacturers hold a share over 65%.
North America is the largest market, with a share over 35%, followed by Europe and Asia Pacific, both have a share nearly 60 percent. In terms of product, In Vitro Assay Kit is the largest segment, with a share over 95%. And in terms of application, the largest application is Academic Institution, followed by Biotech Companies, etc.
The global Angiogenesis Assay market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation

Scope of Angiogenesis Assay Sales Market Report

Report Metric Details
Report Name Angiogenesis Assay Sales Market
Forecasted market size in 2031 US$ 35.1 million
CAGR 7.8%
Forecasted years 2025 - 2031
By Type: (Dominant Segment vs High-Margin Innovation)
  • In Vitro Assay Kit
  • In Vivo Assay Kit
By Application: (Core Demand Driver vs Emerging Opportunity)
  • Academic Institution
  • Biotech Companies
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company: Abcam, Bio-Techne, Thermo Fisher Scientific, Cell Biolabs, Inc., BioVision, Inc, PromoCell GmbH, Merck KGaA, Kollodis BioSciences, Sartorius (Essen BioScience), Creative Bioarray
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
  • Chapter 2: Quantitative analysis of Angiogenesis Assay market size and growth potential at global, regional, and country levels.
  • Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
  • Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., In Vivo Assay Kit in China).
  • Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Biotech Companies in India).
  • Chapter 6: Regional revenue breakdown by company, type, application and customer.
  • Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
  • Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 9: Actionable conclusions and strategic recommendations.
  • Why This Report?
  • Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Angiogenesis Assay value chain, addressing:

FAQ for this report

What is the Angiogenesis Assay Sales Market size in 2031?

Ans: The Angiogenesis Assay Sales Market size in 2031 will be US$ 35.1 million.

What is the market share of major companies in Angiogenesis Assay Sales Market?

Ans: Global top five manufacturers hold a share over 65%.

What is the Angiogenesis Assay Sales Market share by type?

Ans: In terms of product, In Vitro Assay Kit is the largest segment, with a share over 95%.

Who are the main players in the Angiogenesis Assay Sales Market report?

Ans: The main players in the Angiogenesis Assay Sales Market are Abcam, Bio-Techne, Thermo Fisher Scientific, Cell Biolabs, Inc., BioVision, Inc, PromoCell GmbH, Merck KGaA, Kollodis BioSciences, Sartorius (Essen BioScience), Creative Bioarray

What are the Application segmentation covered in the Angiogenesis Assay Sales Market report?

Ans: The Applications covered in the Angiogenesis Assay Sales Market report are Academic Institution, Biotech Companies

What are the Type segmentation covered in the Angiogenesis Assay Sales Market report?

Ans: The Types covered in the Angiogenesis Assay Sales Market report are In Vitro Assay Kit, In Vivo Assay Kit

1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 In Vitro Assay Kit
1.2.3 In Vivo Assay Kit
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Academic Institution
1.3.3 Biotech Companies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Angiogenesis Assay Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Angiogenesis Assay Revenue Market Share by Region (2020-2025)
2.4 Global Angiogenesis Assay Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Angiogenesis Assay Market Size and Prospective (2020-2031)
2.5.2 Europe Angiogenesis Assay Market Size and Prospective (2020-2031)
2.5.3 China Angiogenesis Assay Market Size and Prospective (2020-2031)
2.5.4 Japan Angiogenesis Assay Market Size and Prospective (2020-2031)
2.5.5 South Korea Angiogenesis Assay Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Angiogenesis Assay Historic Market Size by Type (2020-2025)
3.2 Global Angiogenesis Assay Forecasted Market Size by Type (2026-2031)
3.3 Different Types Angiogenesis Assay Representative Players
4 Breakdown Data by Application
4.1 Global Angiogenesis Assay Historic Market Size by Application (2020-2025)
4.2 Global Angiogenesis Assay Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in Angiogenesis Assay Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Angiogenesis Assay Players by Revenue (2020-2025)
5.1.2 Global Angiogenesis Assay Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Angiogenesis Assay Revenue
5.4 Global Angiogenesis Assay Market Concentration Analysis
5.4.1 Global Angiogenesis Assay Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Angiogenesis Assay Revenue in 2024
5.5 Global Key Players of Angiogenesis Assay Head office and Area Served
5.6 Global Key Players of Angiogenesis Assay, Product and Application
5.7 Global Key Players of Angiogenesis Assay, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Angiogenesis Assay Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America Angiogenesis Assay Market Size by Type (2020-2025)
6.1.2.2 North America Angiogenesis Assay Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America Angiogenesis Assay Market Size by Application (2020-2025)
6.1.3.2 North America Angiogenesis Assay Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Angiogenesis Assay Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Angiogenesis Assay Market Size by Type (2020-2025)
6.2.2.2 Europe Angiogenesis Assay Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Angiogenesis Assay Market Size by Application (2020-2025)
6.2.3.2 Europe Angiogenesis Assay Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments and Downstream
6.3.1 China Angiogenesis Assay Revenue by Company (2020-2025)
6.3.2 China Market Size by Type
6.3.2.1 China Angiogenesis Assay Market Size by Type (2020-2025)
6.3.2.2 China Angiogenesis Assay Market Share by Type (2020-2025)
6.3.3 China Market Size by Application
6.3.3.1 China Angiogenesis Assay Market Size by Application (2020-2025)
6.3.3.2 China Angiogenesis Assay Market Share by Application (2020-2025)
6.3.4 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments and Downstream
6.4.1 Japan Angiogenesis Assay Revenue by Company (2020-2025)
6.4.2 Japan Market Size by Type
6.4.2.1 Japan Angiogenesis Assay Market Size by Type (2020-2025)
6.4.2.2 Japan Angiogenesis Assay Market Share by Type (2020-2025)
6.4.3 Japan Market Size by Application
6.4.3.1 Japan Angiogenesis Assay Market Size by Application (2020-2025)
6.4.3.2 Japan Angiogenesis Assay Market Share by Application (2020-2025)
6.4.4 Japan Market Trend and Opportunities
6.5 South Korea Market: Players, Segments and Downstream
6.5.1 South Korea Angiogenesis Assay Revenue by Company (2020-2025)
6.5.2 South Korea Market Size by Type
6.5.2.1 South Korea Angiogenesis Assay Market Size by Type (2020-2025)
6.5.2.2 South Korea Angiogenesis Assay Market Share by Type (2020-2025)
6.5.3 South Korea Market Size by Application
6.5.3.1 South Korea Angiogenesis Assay Market Size by Application (2020-2025)
6.5.3.2 South Korea Angiogenesis Assay Market Share by Application (2020-2025)
6.5.4 South Korea Market Trend and Opportunities
7 Key Players Profiles
7.1 Abcam
7.1.1 Abcam Company Details
7.1.2 Abcam Business Overview
7.1.3 Abcam Angiogenesis Assay Introduction
7.1.4 Abcam Revenue in Angiogenesis Assay Business (2020-2025)
7.1.5 Abcam Recent Development
7.2 Bio-Techne
7.2.1 Bio-Techne Company Details
7.2.2 Bio-Techne Business Overview
7.2.3 Bio-Techne Angiogenesis Assay Introduction
7.2.4 Bio-Techne Revenue in Angiogenesis Assay Business (2020-2025)
7.2.5 Bio-Techne Recent Development
7.3 Thermo Fisher Scientific
7.3.1 Thermo Fisher Scientific Company Details
7.3.2 Thermo Fisher Scientific Business Overview
7.3.3 Thermo Fisher Scientific Angiogenesis Assay Introduction
7.3.4 Thermo Fisher Scientific Revenue in Angiogenesis Assay Business (2020-2025)
7.3.5 Thermo Fisher Scientific Recent Development
7.4 Cell Biolabs, Inc.
7.4.1 Cell Biolabs, Inc. Company Details
7.4.2 Cell Biolabs, Inc. Business Overview
7.4.3 Cell Biolabs, Inc. Angiogenesis Assay Introduction
7.4.4 Cell Biolabs, Inc. Revenue in Angiogenesis Assay Business (2020-2025)
7.4.5 Cell Biolabs, Inc. Recent Development
7.5 BioVision, Inc
7.5.1 BioVision, Inc Company Details
7.5.2 BioVision, Inc Business Overview
7.5.3 BioVision, Inc Angiogenesis Assay Introduction
7.5.4 BioVision, Inc Revenue in Angiogenesis Assay Business (2020-2025)
7.5.5 BioVision, Inc Recent Development
7.6 PromoCell GmbH
7.6.1 PromoCell GmbH Company Details
7.6.2 PromoCell GmbH Business Overview
7.6.3 PromoCell GmbH Angiogenesis Assay Introduction
7.6.4 PromoCell GmbH Revenue in Angiogenesis Assay Business (2020-2025)
7.6.5 PromoCell GmbH Recent Development
7.7 Merck KGaA
7.7.1 Merck KGaA Company Details
7.7.2 Merck KGaA Business Overview
7.7.3 Merck KGaA Angiogenesis Assay Introduction
7.7.4 Merck KGaA Revenue in Angiogenesis Assay Business (2020-2025)
7.7.5 Merck KGaA Recent Development
7.8 Kollodis BioSciences
7.8.1 Kollodis BioSciences Company Details
7.8.2 Kollodis BioSciences Business Overview
7.8.3 Kollodis BioSciences Angiogenesis Assay Introduction
7.8.4 Kollodis BioSciences Revenue in Angiogenesis Assay Business (2020-2025)
7.8.5 Kollodis BioSciences Recent Development
7.9 Sartorius (Essen BioScience)
7.9.1 Sartorius (Essen BioScience) Company Details
7.9.2 Sartorius (Essen BioScience) Business Overview
7.9.3 Sartorius (Essen BioScience) Angiogenesis Assay Introduction
7.9.4 Sartorius (Essen BioScience) Revenue in Angiogenesis Assay Business (2020-2025)
7.9.5 Sartorius (Essen BioScience) Recent Development
7.10 Creative Bioarray
7.10.1 Creative Bioarray Company Details
7.10.2 Creative Bioarray Business Overview
7.10.3 Creative Bioarray Angiogenesis Assay Introduction
7.10.4 Creative Bioarray Revenue in Angiogenesis Assay Business (2020-2025)
7.10.5 Creative Bioarray Recent Development
8 Angiogenesis Assay Market Dynamics
8.1 Angiogenesis Assay Industry Trends
8.2 Angiogenesis Assay Market Drivers
8.3 Angiogenesis Assay Market Challenges
8.4 Angiogenesis Assay Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
List of Tables
 Table 1. Global Angiogenesis Assay Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Global Angiogenesis Assay Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 3. Global Market Angiogenesis Assay Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
 Table 4. Global Angiogenesis Assay Revenue (US$ Million) Market Share by Region (2020-2025)
 Table 5. Global Angiogenesis Assay Revenue Share by Region (2020-2025)
 Table 6. Global Angiogenesis Assay Revenue (US$ Million) Forecast by Region (2026-2031)
 Table 7. Global Angiogenesis Assay Revenue Share Forecast by Region (2026-2031)
 Table 8. Global Angiogenesis Assay Market Size by Type (2020-2025) & (US$ Million)
 Table 9. Global Angiogenesis Assay Revenue Market Share by Type (2020-2025)
 Table 10. Global Angiogenesis Assay Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 11. Global Angiogenesis Assay Revenue Market Share by Type (2026-2031)
 Table 12. Representative Players of Each Type
 Table 13. Global Angiogenesis Assay Market Size by Application (2020-2025) & (US$ Million)
 Table 14. Global Angiogenesis Assay Revenue Market Share by Application (2020-2025)
 Table 15. Global Angiogenesis Assay Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 16. Global Angiogenesis Assay Revenue Market Share by Application (2026-2031)
 Table 17. New Sources of Growth in Angiogenesis Assay Application
 Table 18. Global Angiogenesis Assay Revenue by Players (2020-2025) & (US$ Million)
 Table 19. Global Angiogenesis Assay Market Share by Players (2020-2025)
 Table 20. Global Top Angiogenesis Assay Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Angiogenesis Assay as of 2024)
 Table 21. Ranking of Global Top Angiogenesis Assay Companies by Revenue (US$ Million) in 2024
 Table 22. Global 5 Largest Players Market Share by Angiogenesis Assay Revenue (CR5 and HHI) & (2020-2025)
 Table 23. Global Key Players of Angiogenesis Assay, Headquarters and Area Served
 Table 24. Global Key Players of Angiogenesis Assay, Product and Application
 Table 25. Global Key Players of Angiogenesis Assay, Date of Enter into This Industry
 Table 26. Mergers & Acquisitions, Expansion Plans
 Table 27. North America Angiogenesis Assay Revenue by Company (2020-2025) & (US$ Million)
 Table 28. North America Angiogenesis Assay Revenue Market Share by Company (2020-2025)
 Table 29. North America Angiogenesis Assay Market Size by Type (2020-2025) & (US$ Million)
 Table 30. North America Angiogenesis Assay Market Size by Application (2020-2025) & (US$ Million)
 Table 31. Europe Angiogenesis Assay Revenue by Company (2020-2025) & (US$ Million)
 Table 32. Europe Angiogenesis Assay Revenue Market Share by Company (2020-2025)
 Table 33. Europe Angiogenesis Assay Market Size by Type (2020-2025) & (US$ Million)
 Table 34. Europe Angiogenesis Assay Market Size by Application (2020-2025) & (US$ Million)
 Table 35. China Angiogenesis Assay Revenue by Company (2020-2025) & (US$ Million)
 Table 36. China Angiogenesis Assay Revenue Market Share by Company (2020-2025)
 Table 37. China Angiogenesis Assay Market Size by Type (2020-2025) & (US$ Million)
 Table 38. China Angiogenesis Assay Market Size by Application (2020-2025) & (US$ Million)
 Table 39. Japan Angiogenesis Assay Revenue by Company (2020-2025) & (US$ Million)
 Table 40. Japan Angiogenesis Assay Revenue Market Share by Company (2020-2025)
 Table 41. Japan Angiogenesis Assay Market Size by Type (2020-2025) & (US$ Million)
 Table 42. Japan Angiogenesis Assay Market Size by Application (2020-2025) & (US$ Million)
 Table 43. South Korea Angiogenesis Assay Revenue by Company (2020-2025) & (US$ Million)
 Table 44. South Korea Angiogenesis Assay Revenue Market Share by Company (2020-2025)
 Table 45. South Korea Angiogenesis Assay Market Size by Type (2020-2025) & (US$ Million)
 Table 46. South Korea Angiogenesis Assay Market Size by Application (2020-2025) & (US$ Million)
 Table 47. Abcam Company Details
 Table 48. Abcam Business Overview
 Table 49. Abcam Angiogenesis Assay Product
 Table 50. Abcam Revenue in Angiogenesis Assay Business (2020-2025) & (US$ Million)
 Table 51. Abcam Recent Development
 Table 52. Bio-Techne Company Details
 Table 53. Bio-Techne Business Overview
 Table 54. Bio-Techne Angiogenesis Assay Product
 Table 55. Bio-Techne Revenue in Angiogenesis Assay Business (2020-2025) & (US$ Million)
 Table 56. Bio-Techne Recent Development
 Table 57. Thermo Fisher Scientific Company Details
 Table 58. Thermo Fisher Scientific Business Overview
 Table 59. Thermo Fisher Scientific Angiogenesis Assay Product
 Table 60. Thermo Fisher Scientific Revenue in Angiogenesis Assay Business (2020-2025) & (US$ Million)
 Table 61. Thermo Fisher Scientific Recent Development
 Table 62. Cell Biolabs, Inc. Company Details
 Table 63. Cell Biolabs, Inc. Business Overview
 Table 64. Cell Biolabs, Inc. Angiogenesis Assay Product
 Table 65. Cell Biolabs, Inc. Revenue in Angiogenesis Assay Business (2020-2025) & (US$ Million)
 Table 66. Cell Biolabs, Inc. Recent Development
 Table 67. BioVision, Inc Company Details
 Table 68. BioVision, Inc Business Overview
 Table 69. BioVision, Inc Angiogenesis Assay Product
 Table 70. BioVision, Inc Revenue in Angiogenesis Assay Business (2020-2025) & (US$ Million)
 Table 71. BioVision, Inc Recent Development
 Table 72. PromoCell GmbH Company Details
 Table 73. PromoCell GmbH Business Overview
 Table 74. PromoCell GmbH Angiogenesis Assay Product
 Table 75. PromoCell GmbH Revenue in Angiogenesis Assay Business (2020-2025) & (US$ Million)
 Table 76. PromoCell GmbH Recent Development
 Table 77. Merck KGaA Company Details
 Table 78. Merck KGaA Business Overview
 Table 79. Merck KGaA Angiogenesis Assay Product
 Table 80. Merck KGaA Revenue in Angiogenesis Assay Business (2020-2025) & (US$ Million)
 Table 81. Merck KGaA Recent Development
 Table 82. Kollodis BioSciences Company Details
 Table 83. Kollodis BioSciences Business Overview
 Table 84. Kollodis BioSciences Angiogenesis Assay Product
 Table 85. Kollodis BioSciences Revenue in Angiogenesis Assay Business (2020-2025) & (US$ Million)
 Table 86. Kollodis BioSciences Recent Development
 Table 87. Sartorius (Essen BioScience) Company Details
 Table 88. Sartorius (Essen BioScience) Business Overview
 Table 89. Sartorius (Essen BioScience) Angiogenesis Assay Product
 Table 90. Sartorius (Essen BioScience) Revenue in Angiogenesis Assay Business (2020-2025) & (US$ Million)
 Table 91. Sartorius (Essen BioScience) Recent Development
 Table 92. Creative Bioarray Company Details
 Table 93. Creative Bioarray Business Overview
 Table 94. Creative Bioarray Angiogenesis Assay Product
 Table 95. Creative Bioarray Revenue in Angiogenesis Assay Business (2020-2025) & (US$ Million)
 Table 96. Creative Bioarray Recent Development
 Table 97. Angiogenesis Assay Market Trends
 Table 98. Angiogenesis Assay Market Drivers
 Table 99. Angiogenesis Assay Market Challenges
 Table 100. Angiogenesis Assay Market Restraints
 Table 101. Research Programs/Design for This Report
 Table 102. Key Data Information from Secondary Sources
 Table 103. Key Data Information from Primary Sources


List of Figures
 Figure 1. Angiogenesis Assay Product Picture
 Figure 2. Global Angiogenesis Assay Market Share by Type: 2024 VS 2031
 Figure 3. In Vitro Assay Kit Features
 Figure 4. In Vivo Assay Kit Features
 Figure 5. Global Angiogenesis Assay Market Share by Application: 2024 VS 2031
 Figure 6. Academic Institution
 Figure 7. Biotech Companies
 Figure 8. Angiogenesis Assay Report Years Considered
 Figure 9. Global Angiogenesis Assay Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 10. Global Angiogenesis Assay Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Angiogenesis Assay Revenue Market Share by Region: 2020 VS 2024
 Figure 12. North America Angiogenesis Assay Revenue (US$ Million) Growth Rate (2020-2031)
 Figure 13. Europe Angiogenesis Assay Revenue (US$ Million) Growth Rate (2020-2031)
 Figure 14. China Angiogenesis Assay Revenue (US$ Million) Growth Rate (2020-2031)
 Figure 15. Japan Angiogenesis Assay Revenue (US$ Million) Growth Rate (2020-2031)
 Figure 16. South Korea Angiogenesis Assay Revenue (US$ Million) Growth Rate (2020-2031)
 Figure 17. Global Angiogenesis Assay Market Share by Players in 2024
 Figure 18. Global Top Angiogenesis Assay Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Angiogenesis Assay as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by Angiogenesis Assay Revenue in 2024
 Figure 20. North America Angiogenesis Assay Market Share by Type (2020-2025)
 Figure 21. North America Angiogenesis Assay Market Share by Application (2020-2025)
 Figure 22. Europe Angiogenesis Assay Market Share by Type (2020-2025)
 Figure 23. Europe Angiogenesis Assay Market Share by Application (2020-2025)
 Figure 24. China Angiogenesis Assay Market Share by Type (2020-2025)
 Figure 25. China Angiogenesis Assay Market Share by Application (2020-2025)
 Figure 26. Japan Angiogenesis Assay Market Share by Type (2020-2025)
 Figure 27. Japan Angiogenesis Assay Market Share by Application (2020-2025)
 Figure 28. South Korea Angiogenesis Assay Market Share by Type (2020-2025)
 Figure 29. South Korea Angiogenesis Assay Market Share by Application (2020-2025)
 Figure 30. Abcam Revenue Growth Rate in Angiogenesis Assay Business (2020-2025)
 Figure 31. Bio-Techne Revenue Growth Rate in Angiogenesis Assay Business (2020-2025)
 Figure 32. Thermo Fisher Scientific Revenue Growth Rate in Angiogenesis Assay Business (2020-2025)
 Figure 33. Cell Biolabs, Inc. Revenue Growth Rate in Angiogenesis Assay Business (2020-2025)
 Figure 34. BioVision, Inc Revenue Growth Rate in Angiogenesis Assay Business (2020-2025)
 Figure 35. PromoCell GmbH Revenue Growth Rate in Angiogenesis Assay Business (2020-2025)
 Figure 36. Merck KGaA Revenue Growth Rate in Angiogenesis Assay Business (2020-2025)
 Figure 37. Kollodis BioSciences Revenue Growth Rate in Angiogenesis Assay Business (2020-2025)
 Figure 38. Sartorius (Essen BioScience) Revenue Growth Rate in Angiogenesis Assay Business (2020-2025)
 Figure 39. Creative Bioarray Revenue Growth Rate in Angiogenesis Assay Business (2020-2025)
 Figure 40. Bottom-up and Top-down Approaches for This Report
 Figure 41. Data Triangulation
 Figure 42. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4250

This license allows only one user to access the PDF.
Electronic (PDF)

$6375

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$8500

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools